Adam Kelly - CloudMD Software Ex Officer
| DOCRFDelisted Stock | USD 0.03 0 8.50% |
Insider
Adam Kelly is Ex Officer of CloudMD Software Services
| Age | 49 |
| Phone | 888-686-8560 |
| Web | https://investors.cloudmd.ca |
CloudMD Software Management Efficiency
The company has return on total asset (ROA) of (0.0595) % which means that it has lost $0.0595 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8836) %, meaning that it generated substantial loss on money invested by shareholders. CloudMD Software's management efficiency ratios could be used to measure how well CloudMD Software manages its routine affairs as well as how well it operates its assets and liabilities.CloudMD Software Services has accumulated 22.13 M in total debt with debt to equity ratio (D/E) of 0.16, which may suggest the company is not taking enough advantage from borrowing. CloudMD Software Services has a current ratio of 1.64, which is within standard range for the sector. Debt can assist CloudMD Software until it has trouble settling it off, either with new capital or with free cash flow. So, CloudMD Software's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CloudMD Software Services sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CloudMD to invest in growth at high rates of return. When we think about CloudMD Software's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| CPA CPA | National Research Corp | 66 | |
| Kenneth Billard | Cogstate Limited | N/A | |
| Craig Barbarosh | Evolent Health | 52 | |
| Ben Stilwill | Streamline Health Solutions | N/A | |
| MB CCS | Streamline Health Solutions | N/A | |
| Helen Hrdy | National Research Corp | 59 | |
| Rachel Colite | Cogstate Limited | N/A | |
| Tunde Sotunde | Evolent Health | N/A | |
| M Duffy | Evolent Health | 61 | |
| Wendy Lucio | Streamline Health Solutions | N/A | |
| Donald Vick | Streamline Health Solutions | 60 | |
| Peter Grua | Evolent Health | 66 | |
| Connor Yuen | EGF Theramed Health | N/A | |
| MAAA FSA | Evolent Health | 51 | |
| Usama Chaudhry | EGF Theramed Health | 33 | |
| Jacob Goldberger | Streamline Health Solutions | N/A | |
| Aammaad Shams | Evolent Health | 40 | |
| Gregory MS | National Research Corp | N/A | |
| Jon Boumstein | National Research Corp | N/A | |
| BBus CA | Cogstate Limited | N/A | |
| Chris Edgar | Cogstate Limited | N/A | |
Management Performance
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 |
CloudMD Software Services Leadership Team
Elected by the shareholders, the CloudMD Software's board of directors comprises two types of representatives: CloudMD Software inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CloudMD. The board's role is to monitor CloudMD Software's management team and ensure that shareholders' interests are well served. CloudMD Software's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CloudMD Software's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amit Mathur, Pres Operations | ||
| Eric Lalonde, VP Growth | ||
| Bronwyn Ott, VP HR | ||
| Aida Begovic, Ex Solutions | ||
| Lu Barbuto, Ex Solutions | ||
| Jon Harju, VP Engineering | ||
| Melissa Alvares, VP Marketing | ||
| Adam Kelly, Ex Officer | ||
| Karen MD, President, CEO | ||
| Julia Becker, VP Relations | ||
| Angel Paravicini, Sr Success |
CloudMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CloudMD Software a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 | |||
| Profit Margin | (1.06) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 45.4 M | |||
| Shares Outstanding | 293.29 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 0.72 % | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.29 X |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in CloudMD Pink Sheet
If you are still planning to invest in CloudMD Software Services check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CloudMD Software's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |